Goldman Sachs’s ANACOR PHARMACEUTICALS INC COM ANAC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2016
Q2 | – | Sell |
-1,561,729
| Closed | -$83.5M | – | 7597 |
|
|
2016
Q1 | $83.5M | Buy |
1,561,729
+1,176,583
| +305% | +$86.9M | 0.03% | 763 |
|
|
2015
Q4 | $43.5M | Buy |
385,146
+275,228
| +250% | +$30.3M | 0.02% | 1223 |
|
|
2015
Q3 | $12.9M | Buy |
109,918
+97,306
| +772% | +$12.7M | 0.01% | 2045 |
|
|
2015
Q2 | $976K | Sell |
12,612
-47,434
| -79% | -$3.11M | ﹤0.01% | 4560 |
|
|
2015
Q1 | $3.47M | Buy |
60,046
+37,293
| +164% | +$1.58M | ﹤0.01% | 3247 |
|
|
2014
Q4 | $734K | Sell |
22,753
-47,924
| -68% | -$1.44M | ﹤0.01% | 4898 |
|
|
2014
Q3 | $1.73M | Buy |
70,677
+19,287
| +38% | +$392K | ﹤0.01% | 4082 |
|
|
2014
Q2 | $911K | Buy |
+51,390
| New | +$827K | ﹤0.01% | 4775 |
|
|
2014
Q1 | – | Sell |
-11,063
| Closed | -$186K | – | 7172 |
|
|
2013
Q4 | $186K | Buy |
+11,063
| New | +$153K | ﹤0.01% | 6003 |
|
|
2013
Q3 | – | Sell |
-13,735
| Closed | -$77K | – | 6935 |
|
|
2013
Q2 | $77K | Buy |
+13,735
| New | +$83.2K | ﹤0.01% | 5948 |
|